Compliance promotion needs tailor-made approach;Theoretische en empirische analyse NIVEL: Maatwerk

Pharmaceutisch Weekblad

Volumn 142, Issue 5, 2007, Pages 22-25

  Van Dijk, Liset ^a   Van Dulmen, Sandra ^a   Bensing, Jozien ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; DISEASE CLASSIFICATION; EXPERIMENTAL STUDY; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; HYPERTENSION; INTERVENTION STUDY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PHYSICAL DISEASE; PRESCRIPTION; RISK FACTOR; SOCIOECONOMICS; WORLD HEALTH ORGANIZATION;

EID: 33847407007     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Zie voor de literatuurreferenties de digitale versie van dit artikel op pw.nl.